Disparity in heart defect treatment across genders in North Indian children

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |June 23, 2016
    PubMed

    Insights

    Boys in Northern India with heart conditions receive cardiac treatment more often than girls. This disparity persists even when corrective procedures are free, highlighting a significant gender gap in pediatric cardiac care access.

    Area of Science:

    • Pediatric Cardiology
    • Health Disparities
    • Medical Ethics

    Background:

    • Congenital heart defects (CHDs) affect children globally.
    • Access to timely and appropriate cardiac treatment is crucial for favorable outcomes.
    • Gender-based disparities in healthcare access are documented in various global contexts.

    Purpose of the Study:

    • To investigate potential gender-based disparities in the treatment of heart problems among children in Northern India.
    • To determine if socioeconomic factors, such as free treatment availability, mitigate these disparities.

    Main Methods:

    • Retrospective analysis of pediatric cardiac patient data from Northern India.
    • Comparison of treatment rates between male and female patients with similar cardiac conditions.
    • Statistical analysis to assess the significance of observed differences.

    Main Results:

    • Boys with heart problems were significantly more likely to undergo corrective treatment compared to girls.
    • This disparity was observed across various types of cardiac conditions.
    • The difference in treatment rates remained significant even when the treatment was provided free of cost.

    Conclusions:

    • A notable gender disparity exists in accessing corrective cardiac treatment for children in Northern India.
    • Free treatment initiatives may not be sufficient to overcome underlying gender-based barriers to care.
    • Further research is needed to identify and address the root causes of this inequity in pediatric cardiac care.

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    636
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    423
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    725
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    591
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    469
    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
    3.4K